Baijin Life Science Holdings Limited
Research Baijin Life Science Holdings Limited (1466.HK) on Bullrun: market cap HKD 1.54B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1466.HK
- ExchangeHK
- CountryHong Kong
- SectorConsumer Cyclical
- IndustryLuxury Goods
- CurrencyHKD
- Market capHKD 1.54B
- Financial periodFY2026
- RevenueHKD 89.30M
- Revenue growth-34.1%
- Net income-HKD 37.87M
- Free cash flow-HKD 22.73M
- Gross margin7.5%
Valuation Snapshot
latest market cap is HKD 1.54B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | HKD 89.30M | -HKD 37.87M | -HKD 22.73M | 7.5% | n/a | HKD 43.11M | HKD 28.41M | HKD 185.19M |
| FY2025 | HKD 135.56M | -HKD 316.00K | -HKD 32.97M | 31.0% | 0 | HKD 47.77M | HKD 99.93M | HKD 139.28M |
| FY2024 | HKD 53.68M | -HKD 7.45M | -HKD 6.64M | 33.7% | -0.01 | HKD 37.88M | HKD 51.19M | HKD 96.31M |
| FY2023 | HKD 86.88M | HKD 8.68M | -HKD 21.55M | 9.0% | 0.01 | HKD 41.26M | HKD 2.76M | HKD 78.29M |
| FY2022 | n/a | n/a | n/a | n/a | -0.04 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 1.54B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
About Baijin Life Science Holdings Limited
Baijin Life Science Holdings Limited, together with its subsidiaries, engages in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People's Republic of China, the United States, and internationally. It operates through three segments: Jewellery Business, Skincare Business, and Strategic Investment. The company is involved in the research and development of cellular and large molecule drugs; clinical research services;
Related stock research
Other Consumer Cyclical stocks
Frequently asked questions
What is Baijin Life Science Holdings Limited's market cap?
Baijin Life Science Holdings Limited's market capitalization is HKD 1.54B.
What does Baijin Life Science Holdings Limited do?
Baijin Life Science Holdings Limited, together with its subsidiaries, engages in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People's Republic of China, the United States, and internationally. It operates through three segments: Jewellery Business, Skincare Business, and Strategic Investment.